Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Caroline Baynard"'
Autor:
Sidnee L. Hedrick, Dan Luo, Sophia Kaska, Kumar Kulldeep Niloy, Karen Jackson, Rupam Sarma, Jamie Horn, Caroline Baynard, Markos Leggas, Eduardo R. Butelman, Mary Jeanne Kreek, Thomas E. Prisinzano
Publikováno v:
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-18 (2021)
Abstract Background One of the most prominent opioid analgesics in the United States is the high potency agonist fentanyl. It is used in the treatment of acute and chronic pain and as an anesthetic adjuvant. When used inappropriately, however, ingest
Externí odkaz:
https://doaj.org/article/0172c767eb1349eabd1061749c3e207b
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
The kappa-opioid receptor (KOR) / dynorphin system is implicated with behavioral and neurobiological effects of stress exposure (including heavy exposure to drugs of abuse) in translational animal models. Thus some KOR-antagonists can decrease the av
Externí odkaz:
https://doaj.org/article/74195c65d3ad482d82f32479d63b6f1e
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
The kappa-opioid receptor (KOR) / dynorphin system is implicated with behavioral and neurobiological effects of stress exposure (including heavy exposure to drugs of abuse) in translational animal models. Thus some KOR-antagonists can decrease the av
Autor:
Mary Jeanne Kreek, Dan Luo, Markos Leggas, Sidnee L. Hedrick, Karen S. Jackson, Thomas E. Prisinzano, Sophia Kaska, Jamie Horn, Kumar Kulldeep Niloy, Caroline Baynard, Eduardo R. Butelman, Rupam Sarma
Publikováno v:
Journal of Biomedical Science
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-18 (2021)
Journal of Biomedical Science, Vol 28, Iss 1, Pp 1-18 (2021)
Background One of the most prominent opioid analgesics in the United States is the high potency agonist fentanyl. It is used in the treatment of acute and chronic pain and as an anesthetic adjuvant. When used inappropriately, however, ingestion of ju
Autor:
Mary Jeanne Kreek, Eduardo R. Butelman, Caroline Baynard, Bryan D. McElroy, Thomas E. Prisinzano
Publikováno v:
Journal of psychopharmacology (Oxford, England). 35(5)
Background: Novel short-acting κ(kappa)-opioid receptor selective antagonists are translational tools to examine the impact of the κ-receptor/dynorphin system in assays related to central nervous system dysfunction (e.g., substance use disorders, a